These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1175 related items for PubMed ID: 19696641

  • 1. HLA-specific antibodies developed in the first year posttransplant are predictive of chronic rejection and renal graft loss.
    Lee PC, Zhu L, Terasaki PI, Everly MJ.
    Transplantation; 2009 Aug 27; 88(4):568-74. PubMed ID: 19696641
    [Abstract] [Full Text] [Related]

  • 2. Detailed examination of HLA antibody development on renal allograft failure and function.
    Zhu L, Lee PC, Everly MJ, Terasaki PI.
    Clin Transpl; 2008 Aug 27; ():171-87. PubMed ID: 19711514
    [Abstract] [Full Text] [Related]

  • 3. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
    Meng HL, Jin XB, Li XT, Wang HW, Lü JJ.
    Chin Med J (Engl); 2009 Feb 20; 122(4):420-6. PubMed ID: 19302748
    [Abstract] [Full Text] [Related]

  • 4. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
    Lee PC, Ozawa M.
    Clin Transpl; 2007 Feb 20; ():219-26. PubMed ID: 18642453
    [Abstract] [Full Text] [Related]

  • 5. Anti-human leukocyte antigen and donor-specific antibodies detected by luminex posttransplant serve as biomarkers for chronic rejection of renal allografts.
    Lachmann N, Terasaki PI, Budde K, Liefeldt L, Kahl A, Reinke P, Pratschke J, Rudolph B, Schmidt D, Salama A, Schönemann C.
    Transplantation; 2009 May 27; 87(10):1505-13. PubMed ID: 19461487
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Excellent renal allograft survival in donor-specific antibody positive transplant patients-role of intravenous immunoglobulin and rabbit antithymocyte globulin.
    Mai ML, Ahsan N, Wadei HM, Genco PV, Geiger XJ, Willingham DL, Taner CB, Hewitt WR, Grewal HP, Nguyen JH, Hughes CB, Gonwa TA.
    Transplantation; 2009 Jan 27; 87(2):227-32. PubMed ID: 19155977
    [Abstract] [Full Text] [Related]

  • 8. Donor-specific HLA antibodies in chronic renal allograft rejection: a prospective trial with a four-year follow-up.
    Lachmann N, Terasaki PI, Schönemann C.
    Clin Transpl; 2006 Jan 27; ():171-99. PubMed ID: 18365377
    [Abstract] [Full Text] [Related]

  • 9. Abrogation of anti-HLA antibodies via proteasome inhibition.
    Trivedi HL, Terasaki PI, Feroz A, Everly MJ, Vanikar AV, Shankar V, Trivedi VB, Kaneku H, Idica AK, Modi PR, Khemchandani SI, Dave SD.
    Transplantation; 2009 May 27; 87(10):1555-61. PubMed ID: 19461494
    [Abstract] [Full Text] [Related]

  • 10. Immunological monitoring of posttransplant allograft sensitization following living related donor renal transplantation.
    Panigrahi A, Deka R, Bhowmik D, Tiwari SC, Mehra NK.
    Transplant Proc; 2004 Jun 27; 36(5):1336-9. PubMed ID: 15251326
    [Abstract] [Full Text] [Related]

  • 11. Frequency and clinical implications of development of donor-specific and non-donor-specific HLA antibodies after kidney transplantation.
    Hourmant M, Cesbron-Gautier A, Terasaki PI, Mizutani K, Moreau A, Meurette A, Dantal J, Giral M, Blancho G, Cantarovich D, Karam G, Follea G, Soulillou JP, Bignon JD.
    J Am Soc Nephrol; 2005 Sep 27; 16(9):2804-12. PubMed ID: 16014742
    [Abstract] [Full Text] [Related]

  • 12. Anti-HLA antibodies and kidney allograft outcomes in recipients with donor bone marrow cell infusion.
    Solgi G, Pourmand G, Mehrsai A, Taherimahmoudi M, Nicknam MH, Ebrahimi Rad MR, Seraji A, Asadpoor A, Ansaripor B, Nikbin B, Amirzargar A.
    Iran J Immunol; 2010 Mar 27; 7(1):18-29. PubMed ID: 20371916
    [Abstract] [Full Text] [Related]

  • 13. Prevalence and significance of anti-HLA and donor-specific antibodies long-term after renal transplantation.
    Cardarelli F, Pascual M, Tolkoff-Rubin N, Delmonico FL, Wong W, Schoenfeld DA, Zhang H, Cosimi AB, Saidman SL.
    Transpl Int; 2005 May 27; 18(5):532-40. PubMed ID: 15819801
    [Abstract] [Full Text] [Related]

  • 14. Donor-specific HLA alloantibodies: long-term impact on cardiac allograft vasculopathy and mortality after heart transplant.
    Kaczmarek I, Deutsch MA, Kauke T, Beiras-Fernandez A, Schmoeckel M, Vicol C, Sodian R, Reichart B, Spannagl M, Ueberfuhr P.
    Exp Clin Transplant; 2008 Sep 27; 6(3):229-35. PubMed ID: 18954302
    [Abstract] [Full Text] [Related]

  • 15. Role of human leukocyte antigen, donor-specific antibodies, and their impact in renal transplantation.
    Thiyagarajan UM, Bagul A, Frost J, Horsburgh T, Nicholson ML.
    Transplant Proc; 2012 Jun 27; 44(5):1231-5. PubMed ID: 22663991
    [Abstract] [Full Text] [Related]

  • 16. Posttransplantation production of donor HLA-specific antibodies as a predictor of renal transplant outcome.
    Worthington JE, Martin S, Al-Husseini DM, Dyer PA, Johnson RW.
    Transplantation; 2003 Apr 15; 75(7):1034-40. PubMed ID: 12698094
    [Abstract] [Full Text] [Related]

  • 17. Pre- and posttransplantation allosensitization in heart allograft recipients: major impact of de novo alloantibody production on allograft survival.
    Ho EK, Vlad G, Vasilescu ER, de la Torre L, Colovai AI, Burke E, Deng M, Schwartz J, Marboe C, Mancini D, Opelz G, Suciu-Foca N.
    Hum Immunol; 2011 Jan 15; 72(1):5-10. PubMed ID: 20971146
    [Abstract] [Full Text] [Related]

  • 18. Effect of anti-HLA antibodies on the long-term survival of heart and kidney allografts.
    Barr ML, Cohen DJ, Benvenisty AI, Hardy M, Reemtsma K, Rose EA, Marboe CC, D'Agati V, Suciu-Foca N, Reed E.
    Transplant Proc; 1993 Feb 15; 25(1 Pt 1):262-4. PubMed ID: 8438294
    [Abstract] [Full Text] [Related]

  • 19. Early acute rejection does not affect chronic allograft nephropathy and death censored graft failure.
    He X, Johnston A.
    Transplant Proc; 2004 Dec 15; 36(10):2993-6. PubMed ID: 15686679
    [Abstract] [Full Text] [Related]

  • 20. 14th International HLA and Immunogenetics Workshop: report on the Prospective Chronic Rejection Project.
    Ozawa M, Terasaki PI, Lee JH, Castro R, Alberu J, Alonso C, Alvarez I, Toledo R, Alvez H, Monterio M, Teixeira J, Campbell P, Ciszek M, Charron D, Gautreau C, Christiansen F, Conca R, Gomez B, Monteon F, Grosse-Wilde H, Heinemann F, Humar I, Kamoun M, Kimball P, Kobayashi T, Kupatawintu P, Leech S, LeFor W, Mehra N, Panigrahi A, Naumova E, Norman D, Piazza A, Poli F, Colombo B, Roy R, Schonemann C, Sireci G, Tanabe K, Ishida H, Van den Berg-Loonen E, Zeevi A.
    Tissue Antigens; 2007 Apr 15; 69 Suppl 1():174-9. PubMed ID: 17445195
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 59.